KPTI
Karyopharm Therapeutics
$7.09
−$0.32 (−4.32%)Jul 27, 2026
Key metrics
The numbers that frame KPTI today
- Market cap
- $160.68M
- P/E (TTM)
- -0.8
- EV / FCF
- -5.1
- Gross margin
- 96%
- EV / Sales
- 2.0
- ROIC
- -88.4%
- Div yield
- 0%
- 52wk Low
- $3.65
- 52wk High
- $10.99
Growth
Revenue and earnings trend for KPTI
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about KPTI
Is Karyopharm Therapeutics a good buy?
Yes. Karyopharm Therapeutics has mixed quality and excellent momentum. Taken together, the setup leans positive. Growth looks excellent, which supports the long-term business case. We think Karyopharm Therapeutics is selling at a very high price, which cuts against the buy case.
What is the market capitalization of KPTI?
Karyopharm Therapeutics's market capitalization is $160.68M.
What is the P/E ratio for KPTI stock?
Karyopharm Therapeutics's current P/E ratio is -0.8.
What is the 52-week high for KPTI stock?
The 52-week high for Karyopharm Therapeutics is $10.99. The current close of $7.09 is 35.5% below that high.
What is the 52-week low for KPTI stock?
The 52-week low for Karyopharm Therapeutics is $3.65. The current close of $7.09 is 94.2% above that low.
Does KPTI stock pay dividends?
Karyopharm Therapeutics does not currently show a dividend per share in the company data.